Sara Ravaioli

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Venues

Cancer immunology, immunotherapy : CII

Histopathology

Diagnostic pathology

International journal of environmental research and public health

IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

This page only lists publications with an associated author ORCID identifier.

Affiliation History

IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Nov 09 2015

Italy

biologo :: laboratorio di bioscienze

Publications

Iros Barozzi, Neil Slaven, Eleonora Canale, Rui Lopes, Inês A M Barbosa, Melusine Bleu, Diana Ivanoiu, Claudia Pacini, Emanuela Mensa, Alfie Chambers, Sara Bravaccini, Sara Ravaioli, Gyorffy Balazs, Maria Vittoria Dieci, Giancarlo Pruneri, Giorgio Giacomo Galli, Luca Magnani
A functional survey of the regulatory landscape of estrogen-receptor-positive breast cancer evolution. Cancer discovery (2024)
Michela Cortesi, Michele Zanoni, Roberta Maltoni, Sara Ravaioli, Maria Maddalena Tumedei, Francesca Pirini, Sara Bravaccini
TROP2 (trophoblast cell-surface antigen 2): a drug target for breast cancer. Expert opinion on therapeutic targets 26 (7) (2022)
Sara Bravaccini, Sara Ravaioli, Maria Maddalena Tumedei, Andrea Rocca, Michela Palleschi, Maurizio Puccetti, Paola Parrella, Mattia Altini, Roberta Maltoni
Atezolizumab Plus Nab-paclitaxel in PD-L1-Positive TNBC-Letter. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (14) (2021)
Michela Cortesi, Michele Zanoni, Francesca Pirini, Maria Maddalena Tumedei, Sara Ravaioli, Ilario Giovanni Rapposelli, Giovanni Luca Frassineti, Sara Bravaccini
Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight. International journal of molecular sciences 23 (1) (2021)
Pasquale Simeone, Stefano Tacconi, Serena Longo, Paola Lanuti, Sara Bravaccini, Francesca Pirini, Sara Ravaioli, Luciana Dini, Anna Maria Giudetti
Expanding Roles of De Novo Lipogenesis in Breast Cancer. International journal of environmental research and public health 18 (7) (2021)
Roberta Maltoni, Michela Palleschi, Sara Ravaioli, Maria Maddalena Tumedei, Mattia Altini, Sara Bravaccini
Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be gold. Diagnostic pathology 15 (1) (2020)
Sara Ravaioli, Francesco Limarzi, Maria Maddalena Tumedei, Michela Palleschi, Roberta Maltoni, Sara Bravaccini
Are we ready to use TMB in breast cancer clinical practice? Cancer immunology, immunotherapy : CII 69 (10) (2020)
Michela Palleschi, Roberta Maltoni, Sara Ravaioli, Alessandro Vagheggini, Francesca Mannozzi, Francesca Fanini, Francesca Pirini, Maria Maddalena Tumedei, Eleonora Barzotti, Lorenzo Cecconetto, Samanta Sarti, Silvia Manunta, Paola Possanzini, Anna Fedeli, Annalisa Curcio, Mattia Altini, Ugo De Giorgi, Andrea Rocca, Sara Bravaccini
Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience. Diagnostics (Basel, Switzerland) 10 (8) (2020)
Sara Bravaccini, Lauro Bucchi, Maurizio Puccetti, Sara Ravaioli, Maria Maddalena Tumedei, Patrizia Serra, Carla Masini, Jackson Kahima, Nestory Masalu, Dino Amadori
Explaining the aggressiveness of breast cancer in sub-Saharan African patients. Journal of clinical pathology 72 (10) (2019)
Giuseppe Bronte, Andrea Rocca, Sara Ravaioli, Emanuela Scarpi, Massimiliano Bonafè, Maurizio Puccetti, Roberta Maltoni, Daniele Andreis, Giovanni Martinelli, Sara Bravaccini
Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer? Journal of oncology 2019 (2019)
Maurizio Puccetti, Sara Ravaioli, Maria M Tumedei, Elisa Bucchi, Manuela Malmesi, Laura Medri, Sara Bravaccini
Are fine-needle aspiration biopsy-derived cell blocks a useful surrogate for tissue samples in breast cancer? Histopathology 73 (5) (2018)
Sara Ravaioli, Maria Maddalena Tumedei, Flavia Foca, Roberta Maltoni, Andrea Rocca, Ilaria Massa, Elisabetta Pietri, Sara Bravaccini
Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma in situ treated with surgery and radiotherapy. International journal of experimental pathology 98 (5) (2017)

Sara Ravaioli.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sara Ravaioli